"We have found that gene expression patterns in a subset of these resistant cancer cells differ from those associated with the bulk of the epithelial cells in the tumor. These patterns resemble expression patterns more closely associated with cells with a mesenchymal (a form of connective tissue) phenotype (or appearance)," said Dr. Jenny Chang (http://www.bcm.edu/breastcenter/?PMID=10728), medical director of the Sue and Lester Smith Breast Center (http://www.bcm.edu/cancercenter/) at BCM and a professor of medicine. Chang is a senior author of the paper along with Drs. Michael Lewis and Jeffrey M. Rosen, both of BCM and the Dan L. Duncan Cancer Center (http://www.bcm.edu/cancercenter/) as well as the Breast Center.
In a previous paper, the authors showed that after patients received conventional chemotherapy, the remaining tumor contained a higher percentage of tumor-initiating cells, also known as breast cancer stem cells. These remaining tumor-initiating cells were therefore largely resistant to conventional treatments.
They found that gene expression patterns in these chemoresistant cells represented a tumor-initiating gene signature, which was not only more easily detectable in a newly-defined breast cancer subtype called "claudin-low", but also enriched in human breast tumors after they had been treated with anti-cancer drugs that target the signals of hormones, said Chang. They also found that genes associated with the mesenchymal cell phenotype were increased in breast tumors after hormone treatment.
"This study supports a growing body of evidence that there is a particular subpopulation of cells in breast cancer that may be responsible for disease recurrence, resistance to treatment, and perhaps metastasis (cancer spread)," said Chang.
In the future, she said, the group will be looking at ways to use the gene signature they have identified to develop drugs that can combine with conventional therapy to eradicate all populations of cells within tumors.
Others who took part in this research include Chad J. Creighton, Xiaoxian Li, Melissa Landis, Helen Wong, Angel Rodriguez, Jason I. Herschkowitz, Xiamoei Zhang, Anne Pavlick, M. Carolina Gutierrez, and Susan G. Hilsenbeck, all of the Dan L. Duncan Cancer Center at BCM; J. Michael Dixon, Lorna Renshaw, Alexey A. Larionov and Dana Faratian of Western General Hospital in Edinburgh, UK;Veronique M. Neumeister, Ashley Sjohund, David L. Rimm and Xiaping He, all of Yale University School of Medicine in New Haven, CT; Cheng Fan and Charles M. Perou, both of Unversity of North Carolina at Chapel Hill.
Funding for this study came from the Breast Cancer Research Fundation, the Helis Foundation, the National Cancer Institute Breast Cancer Special Program of Research Excellence, the National Cancer Institute, the Breakthrough Research Unit in Edinburgh, Cancer Research UK, the National Institutes of Health, Glaxo Smith Kline and the U.S. Army Medical Research and Materiel Command.
For more information on basic science research at Baylor College of Medicine, please go to www.bcm.edu/fromthelab or www.bcm.edu/news.
Building a brain, cell by cell: Researchers make a mini neuron network (of two)
23.05.2018 | Institute of Industrial Science, The University of Tokyo
Research reveals how order first appears in liquid crystals
23.05.2018 | Brown University
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
23.05.2018 | Life Sciences
23.05.2018 | Life Sciences
23.05.2018 | Physics and Astronomy